Tapentadol is partly metabolized through the hepatic enzymes CYP2C9, CYP2C19, and CYP2D6 so it innately has interactions with drugs that boost or repress the activity/expression of one or more of such enzymes, in addition to with substrates of such enzymes (on account of competition to the enzyme); some enzyme mediators/substrates require dosing ch… Read More